Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 8Leukemia, Myeloid, Acute 6Neoplasm Metastasis 4Leukemia, Myelomonocytic, Acute 4Leukemia, Monocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Lung Neoplasms 3Endometrial Neoplasms 3Congenital Abnormalities 3Colonic Neoplasms 3Breast Neoplasms 3Sarcoma 2Oropharyngeal Neoplasms 2Neuroblastoma 2Melanoma 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Leukemia 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Anus Neoplasms 2Ureteral Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Stage I Mixed Cell Type Kidney Wilms Tumor 1

Interventions

Watchful Waiting 1Vincristine 1Radiotherapy, Conformal 1Radiotherapy 1Platinum 1Observation 1Methylphenidate 1Mesna 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Fentanyl 1Etoposide 1Donepezil 1Cyclophosphamide 1Cisplatin 1Carboplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Ependymoma × Observation × Clear all
NCT01096368 2026-04-30

Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma

Children's Oncology Group

Phase 3 Completed
479 enrolled 24 charts

Ependymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡